![Medicine / Antiretroviral drug / Protease inhibitor / Food and Drug Administration / HIV / Polypharmacy / Norfloxacin / Clinical trial / Pharmaceutical sciences / Pharmacology / Health Medicine / Antiretroviral drug / Protease inhibitor / Food and Drug Administration / HIV / Polypharmacy / Norfloxacin / Clinical trial / Pharmaceutical sciences / Pharmacology / Health](https://www.pdfsearch.io/img/7a7e2416375a16a2c251cd7de8894cd5.jpg)
| Open Document File Size: 1,93 MBShare Result on Facebook
City Reference / / Company The Health Resources / AEs / Treatment Group / ITT / / Country United States / / Event FDA Phase / / Facility Laboratory Toxicities / Laboratory Findings / / IndustryTerm Treatment of HIV / / MedicalCondition HIV infection / HIV / Infection / neutropenia / / MedicalTreatment Antiretroviral Therapy / / Organization FDA / National Institute of Health / Advisory Committee / MD NDA / PDUFA Goal Date Division / / Person Review Neil Rellosa / Neil Rellosa / / Product Lexiva / age / Lexiva® (fosamprenavir) Oral / S28 / / PublishedMedium Baseline / / Technology Pharmacokinetics / Pharmacodynamics / /
SocialTag |